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Abstract: This study evaluated the feasibility and acceptability of a self-regulation smartphone app
for reducing prolonged sitting in people with Type 2 diabetes mellitus (T2DM). This was a two-arm,
randomised, controlled feasibility trial. The intervention group used the MyHealthAvatar-Diabetes
smartphone app for 8 weeks. The app uses a number of behaviour change techniques aimed at
reducing and breaking up sitting time. Eligibility, recruitment, retention, and completion rates for
the outcomes (sitting, standing, stepping, and health-related measures) assessed trial feasibility.
Interviews with participants explored intervention acceptability. Participants with T2DM were
randomised to the control (n = 10) and intervention groups (n = 10). Recruitment and retention rates
were 71% and 90%, respectively. The remaining participants provided 100% of data for the study
measures. The MyHealthAvatar-Diabetes app was viewed as acceptable for reducing and breaking
up sitting time. There were preliminary improvements in the number of breaks in sitting per day,
body fat %, glucose tolerance, attitude, intention, planning, wellbeing, and positive and negative
affect in favour of the intervention group. In conclusion, the findings indicate that it would be feasible
to deliver and evaluate the efficacy of the MyHealthAvatar-Diabetes app for breaking up sitting time
and improving health outcomes in a full trial.
Keywords: sedentary behaviour; glucose; health apps; behaviour change; theory of planned
behaviour; health coaching
1. Introduction
The global prevalence of diabetes is estimated to be 415 million [1]. Type 2 diabetes mellitus
(T2DM) accounts for 87–91% of all cases of diabetes and increases the risk of cardiovascular disease
(CVD), premature mortality, poor psychological wellbeing, and reduced quality of life [2,3]. Effective
interventions to manage glycaemia are thus important for reducing the onset of these T2DM-related
health outcomes [4].
Int. J. Environ. Res. Public Health 2020, 17, 4414; doi:10.3390/ijerph17124414 www.mdpi.com/journal/ijerph
Int. J. Environ. Res. Public Health 2020, 17, 4414 2 of 15
Engaging in high amounts of sedentary behaviour is detrimentally associated with the risk of
diabetes, CVD, mortality, and poor mental health, independent of physical activity levels [5–7]. In people
with T2DM, increased sedentary time is associated with higher levels of CVD risk markers, including
hyperglycaemia, insulin resistance, and low high-density lipoprotein cholesterol [8]. Conversely,
an increased number of breaks in sedentary time per day is beneficially associated with glucose
tolerance and triglyceride levels [9]. Experimental studies have also consistently reported attenuations in
postprandial glycaemia in response to regularly breaking up sitting time with light or moderate-intensity
physical activity over a single day [10–14]. People with T2DM have been found to engage in 9.5 h/day
of device-measured sedentary time [15]. Physical activity guidelines for this population thus suggest
reductions in total daily sitting time and regular interruptions to prolonged sitting [16]. However,
there is a paucity of research that has tested interventions for reducing sitting time in people with T2DM
or to understand the determinants of sitting time in this population using theoretical frameworks [17],
such as the Theory of Planned Behaviour [18]. Web-based interventions using such theories have,
however, shown promise in this population to enhance physical activity levels through intervening
with attitudes, subjective norms, perceived behavioural control, and intentions [19].
It is suggested that smartphone apps have the potential to be used as low-cost health behaviour
change interventions [20]. In the UK, 78% of people used a smartphone in 2018 [21], and there are
currently 325,000 mobile health apps available [22]. There have been a limited number of studies
evaluating smartphone app interventions for reducing sitting time [23,24]. These apps include features
to enable monitoring of sitting time, goal-setting, prompts to interrupt sitting, and feedback on
behaviour. App-based interventions have resulted in reductions in total sitting time and an increase
in the number of breaks in sitting per day after one week in the general adult population [23,24].
However, these apps were only tested over a short time period (one week). In a small sample of people
with T2DM (n = 7), daily sedentary time responses to an app that prompted them to break up their
sitting time were varied, from decreases by −13% to increases by 11% [25]. The number of breaks in
sedentary time also unfavourably decreased by 16 breaks per day. These interventions have often
not been explicitly linked to theoretical models or modes of effective delivery, such as motivational
interviewing [26] and health coaching [27]. There has also been limited focus on utilising behaviour
change techniques (BCTs) within these apps [28] to target reductions in total daily and prolonged
sitting time [23]. The aim of this study was, therefore, to evaluate the feasibility and acceptability
of a self-regulation smartphone app with targeted BCTs for reducing prolonged sitting in people
with T2DM.
2. Materials and Methods
2.1. Study Design and Overview
This was a two-arm, randomised, controlled feasibility trial reported in line with the
Consolidated Standards of Reporting Trials (CONSORT) guidelines [29]; see Supplementary Table S1.
Ethical approval was granted by the Cambridge South National Health Services (NHS) Research Ethics
Committee (reference 17/EE/0070) and was registered on the ISRCTN clinical trials registry (number
ISRCTN11167977). The trial was carried out in accordance with the Declaration of Helsinki. All testing
procedures took place at the University of Bedfordshire Sport and Exercise Science Laboratories.
After baseline data collection, participants were randomised in blocks of four with a ratio of 1:1 by the
research team to either the control or intervention group, using an online tool (www.randomization.com).
Participants in the control group received usual care. As this was a feasibility study, the sample size
was pragmatic and not based on a power calculation.
2.2. Participants
Participants were recruited from local GP surgeries, a Diabetes UK support group, and social
media. Inclusion criteria were: males and females aged 18–65 years; self-reported T2DM diagnosed
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within the past four years (early stage) and in the first stage of drug treatment, or using a diet
and exercise management strategy only; able to read and speak English; able to stand and walk
unassisted; and previous experience using a smartphone. Exclusion criteria included: BMI ≥ 40 kg/m2;
cardiovascular disease, kidney disease or hypertension; severe mental health concerns; and pregnancy.
Participants were email or telephone-screened for eligibility, and provided written informed consent
prior to any testing procedures.
2.3. Intervention
Participants randomised to the intervention group were asked to use the MyHealthAvatar-Diabetes
smartphone app for 8 weeks. MyHealthAvatar is a platform developed by the European
Commission-funded research project “MyHealthAvatar: Demonstration of a 4D Digital Avatar
Representation for Access to Long-Term Health Status Information” led by the University
of Bedfordshire to provide digital representation of patients’ health statuses with the aim
of creating a “digital avatar” of the user [30]. The infrastructure enables the collection,
access, and sustainability of health and lifestyle information and is informed by a survey of user
needs [31]. The MyHealthAvatar-Diabetes app is compatible with Android devices and was developed
for the management of health and lifestyle behaviour in patients with diabetes. This app was designed
in collaboration between the authors, and draws on a number of BCTs [28] to encourage reductions in
sitting time, as described below. It specifically uses the BCTs: goal-setting, action planning, review
behaviour goals, discrepancy between current behaviour and the goal, review outcome of goal, feedback
on behaviour, self-monitoring of behaviour, feedback on outcomes of behaviour, information about
health consequences, monitoring of emotional consequences, and prompts/cues. Participants were
provided with an Android smartphone to use if they did not have access to one. The app comprises a
range of suites accessible to the user to encourage reductions in sitting time and improved management
of their disease, as described below.
2.3.1. MyHealthAvatar-Diabetes App
Sitting Behaviour Suite
Sitting time and breaks in sitting per day are monitored in real-time, using a combination of
the smartphone’s built-in accelerometers and gyroscope sensor. This allows monitoring of the angle
change rate for movement in three planes (see Supplementary Figure S1). Sitting and standing postures
are detected using the Y-axis. The general accuracy of mobile sensors for monitoring body positions
when the phone is carried in the pocket is over 90% [32]. If the phone was being used for a call or any
other purpose (meaning the screen was on), this was classified as sitting time if the phone sensors
detected no other movement. Users are able to set self-generated personalised goals and monitor
their progress towards these goals with regard to their total sitting time and breaks in sitting per
day. The data is displayed to the user (see Figure 1) and progress towards each goal is shown as a
bar filling and the corresponding percentage towards that goal. For total daily sitting, 100% would
mean that the user has achieved the maximum amount of time sitting that day relevant to their goal,
while 100% for breaks would mean that they have achieved their daily goal of breaks in sitting per
day. An alert to prompt participants to take a break from sitting was automatically set to occur every
30 min during the day and read “It is time to take a break from sitting”. Users were able to achieve a
maximum of one break within each 30 min period (e.g., they could achieve a maximum of 20 breaks
over a 10 h period). A break was defined as engaging in ≥2 min of continuous ambulation and/or
standing [10–12], which is displayed to the user. All intervention participants were asked to carry the
smartphone in their front trouser pocket throughout the study to maximise the phone’s accuracy for
detecting sitting time. The app has a calendar feature where the user can view their data for previous
days. The calendar feature works across all of the suites described here.
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Figure 1. MyHealthAvatar‐Diabetes app sitting suite. 
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The number of steps and time spent  in physical activity are monitored  in real‐time using the 
phone’s in‐built accelerometer and location tracker. Goals can be set for the number of daily steps, 
and the progress toward the daily goal is displayed as a percentage. 
2.3.1.3. Body Weight, Glucose, and Blood Pressure Suites 
There are separate suites where users can enter and monitor their body weight, glucose, and 
blood pressure levels (see Supplementary Figure S2). If participants wished to use these suites, they 
were responsible for obtaining their own readings using devices that they may have available to them 
at home, for example. Values could be entered daily and a graph could be displayed, showing their 
values over  time. Goals could be set  for body weight, and progress  towards  their goal would be 
displayed in percentage terms. For the body weight suite, participants could also enter their height 
so that their BMI would be calculated and displayed. The app displays whether the user’s BMI  is 
within the underweight, normal weight, overweight, or obese range. 
2.3.1.4. Medication Alerts, Mood, and Diabetes Information Suites 
Users can set medication alerts  to occur at relevant  times  throughout  the day based on  their 
personal medication regime. An alert will appear on the screen accompanied by an alarm at the times 
specified. The mood suite enables the user to enter their current mood at any time during the day on 
a five‐point scale of “very sad” to “very happy”. The average mood of the entries for that day would 
then be displayed graphically to the user (see Supplementary Figure S2). Participants are also able to 
complete a weekly mood questionnaire via the Positive and Negative Affect Scale [33], which would 
then display their positive and negative affect scores. The information section of this suite encouraged 
the user to “try to improve your mood by being more active and sitting less”. There is also a suite for 
users to access information on diabetes, where there are links to recent diabetes‐related NHS news 
articles. 
2.3.2. Text Message Support 
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Body Weight, Glucose, and Blood Pressure Suites
There are separate suites where users can enter and monitor their body weight, glucose, and blood
pressure levels (see Supplementary Figure S2). If participants wished to use these suites, they were
responsible for obtaining their own readings using devices that they may have available to them at
home, for example. Values could be entered daily and a graph could be displayed, showing their
values over time. Goals could be set for body weight, and progress towards their goal would be
displayed in percentage terms. For the body weight suite, participants could also enter their height so
that their BMI would be calculated and displayed. The app displays whether the user’s BMI is within
the underweight, normal weight, overweight, or obese range.
Medication Alerts, Mood, and Diabetes Information Suites
Users can set medication alerts to occur at relevant times throughout the day based on their
personal medication regime. An alert will appear on the screen accompanied by an alarm at the times
specified. The mood suite enables the user to enter their current mood at any time during the day
on a five-point scale of “very sad” to “very happy”. The average mood of the entries for that day
would then be displayed graphically to the user (see Supplementary Figure S2). Participants are
also able to complete a weekly mood questionnaire via the Positive and Negative Affect Scale [33],
which would then display their positive and negative affect scores. The information section of this
suite encouraged the user to “try to improve your mood by being more active and sitting less”. There is
also a suite for users to access information on diabetes, where there are links to recent diabetes-related
NHS news articles.
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2.3.2. Text Message Support
In addition to the MyHealthAvatar-Diabetes app, participants received two text messages per week,
sent on Monday and Friday from the research team to encourage reductions in sitting. Text message
content was based on motivational interviewing [26] and the Goal, Reality, Opportunity, and Will
(GROW) model of health coaching [27] (see Supplementary File S2) and used a combined communication
approach to deliver the BCTs to enhance intrinsic motivation, as previously recommended [34–36].
2.4. Data Collection
Data collection took place at baseline and 8 weeks (end of the intervention period). Participants
were asked to fast for ≥10 h and not consume alcohol or caffeine for 24 h prior to the morning of
each data collection session. They were required not to engage in any exercise for 48 h prior to data
collection, and to travel to the laboratories by car to minimise their activity levels during that morning.
Upon arrival, participants had a fasting blood sample taken, and then completed an oral glucose
tolerance test (OGTT). They then had other anthropometric and cardiometabolic health measures taken,
and completed questionnaires as described below.
2.5. Primary Outcomes (Feasibility and Acceptability)
Eligibility, recruitment, and retention rates were recorded to assess trial feasibility in addition to
completion rates for the outcomes that would be planned in a full trial. Furthermore, acceptability of
the intervention was assessed using semi-structured interviews with each intervention participant to
explore the experience of using the intervention and barriers and facilitators to their engagement with
the MyHealthAvatar-Diabetes app.
2.6. Secondary Outcomes
2.6.1. Sitting, Standing, and Stepping
An activPAL activity monitor (PAL Technologies Ltd., Glasgow, Scotland) was attached to each
participant’s right thigh using a medical-grade dressing (Hypafix, BSN medical, Hull, UK) to measure
sitting, standing, and stepping outcomes. The activPAL was wrapped in a nitrile sleeve so that it was
waterproof. Participants were asked to wear the device continuously for eight consecutive days at
baseline and during the last week of the intervention. They were provided with a diary to record sleep
and wake times and any periods where the device was removed. The activPAL provides a valid and
reliable measure of sitting, standing, stepping, and postural transitions [37,38].
The activPAL data was processed in STATA (StataCorp LLC, College Station, TX, USA) using
an automated algorithm [39]. A valid day of wear was considered a wear time of >10 h, at least
500 steps, and no more than 95% of data in one activity category (i.e., sitting, standing, or stepping).
For quality control, each valid day was visually compared with diary notes to confirm waking
wear time. The specific outcomes for this study derived from the activPAL included daily sitting,
standing, stepping, light-intensity stepping, and moderate-to-vigorous stepping, each expressed as a
percentage of daily waking wear time to account for any differences in wear time between baseline
and follow-up. Light and moderate-to-vigorous stepping intensities were calculated by the activPAL’s
internal algorithm that is based on step rate [40]. The number of breaks in sitting, number of prolonged
sitting bouts, and total steps per day were also derived. The average across all valid days was calculated
for each of these outcomes.
2.6.2. Anthropometry and Cardiometabolic Health
Height was measured using a stadiometer. Body weight and body fat % were measured using
the TANITA BC-418 Segmental Body Composition Analyzer (Tanita Corp., Tokyo, Japan) which uses
bio-electrical impedance analysis. The waist circumference was measured at the level of the umbilicus
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using an adjustable tape measure. Resting blood pressure was measured using the Omron M5-I
automatic blood pressure monitor (Omron Matsusaka Co Ltd., Matsusaka, Japan). A finger prick
blood sample was collected for measurement of fasting glucose, which was followed by an OGTT,
whereby each participant consumed 75 g of glucose (100% dextrose monohydrate powder; Thornton &
Ross Ltd., UK) mixed with 300 mL of water. A further finger prick blood sample was taken 2 h after
consuming the glucose load for measurement of 2-h glucose. A volume of 30 µL was collected for each
blood sample, and capillary blood glucose concentrations were measured immediately using the YSI
2300 STAT plus glucose and lactate analyzer (YSI Inc., Yellow Springs, OH, USA).
2.6.3. Determinants of Sitting Behaviour, Mood, and Wellbeing
Determinants of sitting behaviour were measured based on the Theory of Planned Behaviour [41]
using standardised wording formats [42], with the behavioural outcome termed “avoid long periods
of sitting” and the duration being over a one-week period, anchored on a seven-point likert
scale. This included four items on attitude (e.g., “Avoiding long periods of sitting would be
harmful/beneficial”), four items on subjective norms (e.g., “Most people who are important to
me think that I should avoid long periods of sitting over the next week”), three items on perceived
behavioural control (e.g., “Whether I avoid long periods of sitting over the next week is entirely up to
me”) and three items on intentions (e.g., “I intend to avoid long periods of sitting over the next week”).
Current mood was assessed using the Positive and Negative Affect Scale [33] and wellbeing using
the Office for National Statistics National Wellbeing Measurement [43] and the Warwick Edinburgh
Mental Wellbeing Scale [44].
2.7. Data Analysis
Data analysis included calculating eligibility (participants eligible/participants assessed for
eligibility × 100), recruitment (participants randomised/number of eligible participants screened × 100),
and retention (participants completing the intervention/participants enrolled × 100) rates, in addition to
completion rates for the data collection measures (participants providing full outcome data/participants
completing the study × 100). Interviews were audio-recorded and transcribed verbatim. Thematic
analysis was used to analyse the interviews [45], which permitted in-depth exploration of participant
perceptions of the intervention. In accordance with recommendations for pilot and feasibility studies,
significance testing was not conducted, as it is inappropriate to place undue significance on hypothesis
testing when no formal power calculations have been performed [46]. Furthermore, there was likely to
be an imbalance in pre-randomisation covariates with small sample sizes, which would need to be
adjusted for in the analysis and which could compromise statistical power [46]. Therefore, this study
calculated Cohen’s d effect sizes to explore preliminary trends in the data (between-group differences).
Effect sizes of 0.2, 0.5, and 0.8 indicated a small, medium, and large effect, respectively. Data are
reported as mean (SD). Descriptive variables were generated using SPSS V.22 (IBM, Armonk, NY, USA).
3. Results
3.1. Feasibility
Figure 2 shows participant progression throughout the study. Participants were recruited from
January 2017 until June 2017 on a rolling basis, with the last follow-up assessment taking place in
August 2017. Of the 50 individuals screened prior to the eligibility assessment, 26% did not respond to
further contact. Of the 37 participants assessed for eligibility, 24% (n = 9) did not meet the inclusion
criteria and 22% (n = 8) declined to take part (eligibility rate = 76%). Nine males and 11 females were
enrolled into the study and randomised to the control or intervention group (recruitment rate = 71%).
Table 1 shows the descriptive characteristics of the participants.
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Figure 2. CONSORT diagram of participant progression through the study [29].
Table 1. Participant characteristics. Data presented as mean (SD).
Characteristic Control Group Intervention Group
Age 55 (6) 57 (7)
Male (n) 6 3
Female (n) 3 6
Body mass index (kg/m2) 29.9 (4.7) 31.1 (6.4)
Body fat % 31.3 (7.8) 36.9 (9.9)
Waist circumference (cm) 107.2 (11.6) 104.6 (14.9)
Resting systolic blood pressure (mmHg) 134 (18) 136 (17)
Resting diastolic blood pressure (mmHg) 83 (11) 84 (9)
Fasting glucose (mmol/L) 6.57 (1.77) 5.76 (0.99)
2-h glucose (mmol/L) 11.64 (3.06) 10.23 (1.86)
One participant withdrew from each arm, meaning that nine participants in each group completed
the study (retention rate = 90%). The 18 participants that completed the study provided 100% of data
for each of the study measures.
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3.2. Participants’ Views on Using the MyHealthAvatar-Diabetes App
There were four themes that were identified from the interviews with regard to participant views
of the acceptability and feasibility of the MyHealthAvatar-Diabetes app. These were (1) “Prompting
behaviour change”, (2) “Sense of achievement”, (3) “Technical issues”, and (4) “Environmental barriers”.
3.2.1. Theme 1—Prompting Behaviour Change
Participants highlighted that the app prompted them to change their behaviour. This was
facilitated by the alert raising their awareness and reminding them to take a break from sitting, and led
to self-realisation of how much time they were spending in prolonged sitting.
“The most useful thing with the app is that it would vibrate every 30 min, which meant I didn’t
have to look at it, I just had it in my pocket and when I felt it vibrate, I would just automatically stand
up” (male, aged 44).
“It made me realise how often I do sit for exceptionally long periods of time, especially during the
workday when you get engrossed in something and you don’t leave, so having the app that did alert
you was useful” (female, aged 54).
3.2.2. Theme 2—Sense of Achievement
Participants reported how the app helped to increase their motivation to reach sitting time and
step goals, which led to a sense of achievement. The goal-setting function of the app was identified as
being particularly helpful in this respect, in addition to being able to self-monitor progress towards
goals in real-time.
“Goals were probably one of the best bits in the app; it showed you how many periods you had
stood up for” (male, aged 44).
“It certainly made me think about how I sit all the time and my frame of mind has changed,
I’m more positive now and I’m out walking with my sister” (female, aged 63).
3.2.3. Theme 3—Technical Issues
Interest and adherence to using the app may have been affected by technical complications.
Participants explained that they would prefer the break reminder alerts to be reactive to the time they
had spent sitting, as opposed to being set to occur every 30 min. Some participants also felt that the
number of steps being recorded was inaccurate when comparing it to other apps and wearable devices
they had access to, such as a Fitbit or Apple iPhone step-counter.
“Every half hour it bleeps at you rather than recording what you are doing and reacting to it. If you
want people to get up every half hour, it needs to tell you when you have sat down” (male, aged 65).
“I’m not sure it was consistent in how it recorded, there was some days where I felt I had done
more walking and I felt it was inconsistent” (female, aged 53).
3.2.4. Theme 4—Environmental Barriers
Environmental barriers to using the app were commonly described, such as ensuring the phone
was charged, remembering to have the phone with you and in your pocket at all times, and having to
wear the phone in a trouser pocket to enable accurate detection of sitting time.
“Remembering to have it in my pocket and also it limits you to what you can wear, I wear a lot of
these jeggings and they don’t have the pockets [in order to carry the phone]” (female, aged 63).
“Just the fact that it’s a mobile phone, it’s not easy to always have it on you. I didn’t always
have clothes where I had a pocket and I didn’t really feel it was that accurate because of that”
(female, aged 60).
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3.3. Changes in Sitting, Standing, and Stepping
The analysis of between-group differences from baseline to follow-up found a large effect for the
change in the number of breaks in sitting per day in favour of the intervention group (see Table 2).
Both the control and intervention groups decreased their percentage of time stepping, but the reduction
was smaller in the intervention group (medium effect). There was also a medium effect for the change
in light stepping time in favour of the intervention group.
Table 2. Within- and between-group differences from baseline to follow-up for sitting, standing,
and stepping outcomes. Data presented as mean (SD).
Variable ControlBaseline
Control
Follow-Up
Within-
Group
Differences
Intervention
Baseline
Intervention
Follow-Up
Within-
Group
Differences
Between-
Group
Differences
Cohen’s d
Waking wear time (min) 959.5(61.7)
948.2
(70.2)
−11.3
(87.1)
936.3
(54.7)
914.6
(55.5)
−21.7
(28.2)
−10.4
(92.6) 0.16
% Sitting 56.8(13.9)
53.2
(13.8)
−0.7
(6.2)
68.2
(8.9)
66.1
(9.6)
−2.1
(7.3)
−1.4
(10.1) 0.21
% Standing 31.2(11.4)
33.4
(12.5)
2.1
(7.4)
21.6
(5.6)
24.0
(6.6)
2.5
(5.2)
0.4
(9.8) 0.06
% Stepping 12.0(3.8)
10.5
(3.5)
−1.5
(3.1)
10.3
(4.2)
9.9
(3.5)
−0.4
(2.6)
1.1
(4.4) 0.38
% Light stepping 4.9(1.5)
4.5
(1.6)
−0.4
(1.4)
3.5
(1.1)
3.9
(1.2)
0.3
(0.8)
0.7
(1.7) 0.61
% MVPA stepping 7.0(2.4)
6.0
(2.2)
−1.1
(2.0)
6.7
(3.3)
6.0
(2.5)
−0.7
(2.0)
−0.4
(3.2) 0.20
Breaks in sitting per day 53.8(19.2)
49.3
(15.6)
−4.4
(15.7)
47.2
(9.9)
51.6
(14.8)
4.3
(6.5)
8.8
(16.9) 0.72
Prolonged sitting bouts
per day
5.0
(1.6)
4.7
(2.1)
−0.3
(1.6)
5.7
(1.1)
5.8
(1.4)
0.1
(1.3)
0.4
(2.5) 0.27
Steps per day 8742.7(2827.4)
7492.2
(2796.1)
−1250.4
(2467.5)
7772.7
(3689.8)
7109.3
(2986.7)
−663.3
(2318.1)
587.1
(3330.0) 0.25
3.4. Changes in Anthropometric and Cardiometabolic Outcomes
There was a medium effect for the change in body fat % and 2-h blood glucose in favour of the
intervention group (see Table 3). The effect sizes for the between-group differences were trivial or
small for the remaining anthropometric and cardiometabolic outcomes.
Table 3. Within- and between-group differences from baseline to follow-up for anthropometric and
cardiometabolic outcomes. Data presented as mean (SD).
Variable ControlBaseline
Control
Follow-up
Within-
Group
Differences
Intervention
Baseline
Intervention
Follow-Up
Within-
Group
Differences
Between-
Group
Differences
Cohen’s d
Weight (kg) 90.2(19.9)
90.5
(19.2)
0.2
(1.7)
89.6
(20.3)
90.0
(21.7)
0.4
(2.8)
0.1
(3.0) 0.09
Body fat % 31.3(7.8)
31.5
(7.8)
0.3
(1.5)
36.9
(9.9)
35.9
(9.2)
−0.9
(2.6)
−1.2
(3.2) 0.57
Body mass index (kg/m2)
29.9
(4.7)
29.9
(4.6)
0.1
(0.6)
31.1
(6.4)
31.2
(6.9)
0.1
(1.1)
0.0
(1.1) 0.00
Waist circumference (cm) 107.2(11.6)
107.9
(11.6)
0.7
(3.6)
104.6
(14.9)
104.7
(14.1)
0.1
(2.1)
−0.6
(3.7) 0.20
Heart rate (bpm) 66.7(10.9)
65.9
(10.0)
−0.8
(5.4)
63.0
(13.8)
61.6
(9.8)
−1.4
(7.6)
−0.7
(12.2) 0.09
Systolic blood pressure
(mmHg)
134.0
(18.1)
135.6
(20.3)
1.6
(12.4)
136.3
(17.2)
138.2
(20.7)
1.9
(13.3)
0.3
(23.2) 0.02
Diastolic blood pressure
(mmHg)
83.3
(10.7)
84.3
(13.2)
1.0
(7.5)
83.8
(9.5)
82.4
(9.8)
−1.3
(9.5)
−2.3
(13.5) 0.27
Fasting blood glucose
(mmol/L)
6.55
(1.76)
6.73
(2.66)
0.19
(1.30)
5.75
(1.01)
5.66
(1.20)
−0.09
(0.66)
−0.28
(1.30) 0.27
2-h blood glucose
(mmol/L)
11.47
(2.96)
11.22
(3.74)
−0.25
(1.78)
10.46
(1.67)
9.56
(1.20)
−0.90
(1.26)
−0.65
(2.69) 0.42
3.5. Changes in Determinants of Sitting Behaviour, Mood, and Wellbeing
For the psychological variables (Supplementary Table S2), in relation to the Theory of Planned
Behaviour, there was a medium effect for changes in attitude in favour of the intervention. Perceived
behavioural control increased in both groups, but more so in the control group. Subjective norms
reduced in the intervention group, relevant to the controls. Self-efficacy increased in favour of the
control group, reducing in the intervention group, and planning increased in favour of the intervention
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group. All elements of wellbeing (general wellbeing, positive affect, and items related to life satisfaction,
worthwhileness, and happiness) changed in favour of the intervention (small to large effect sizes),
while negative affect reduced in favour of the intervention, and anxiety made no change in the
intervention group but reduced in the controls.
4. Discussion
This study demonstrated the feasibility of implementing and evaluating the
MyHealthAvatar-Diabetes smartphone app for reducing prolonged sitting in people with
early-stage T2DM. It was deemed feasible to deliver and evaluate the intervention, evidenced by
the low dropout rate during the study and high compliance with providing outcome measure data.
Valid activPAL data was collected from all of the participants who completed the study, indicating
efficacy of collecting primary outcome data (sitting time) in a fully powered RCT. Those allocated to
the intervention found the app to be an acceptable intervention tool that they cited was particularly
useful for raising awareness of their sitting levels, prompting changes in sitting behaviour and
providing a sense of achievement. Prompting behaviour change was facilitated by the alerts to
take a break from sitting and the real-time self-monitoring of sitting goals. The use of prompts and
self-monitoring of sitting time via computer and smartphone apps has been documented in previous
interventions that have effectively reduced sitting time and increased the number of breaks from
sitting in adults and office workers [23,24,47]. The sense of achievement that resulted from using
the MyHealthAvatar-Diabetes app appeared to be due to the ability to set sitting goals and monitor
progress towards these goals in real-time. There have been a number of studies published in other
population groups in which goal-setting and self-monitoring have been used as part of an effective
multicomponent intervention to reduce sitting [48–50]. This study demonstrates the acceptability of
delivering specific BCTs via a smartphone app for reducing prolonged sitting in people with T2DM.
This study demonstrated the preliminary efficacy of the MyHealthAvatar-Diabetes app for
increasing the number of breaks from sitting per day. A smartphone app (stAPP) aimed at
reducing sitting behaviour that included similar functions to MyHealthAvatar-Diabetes (e.g., real-time
self-monitoring, prompts, goal-setting) significantly increased the number of breaks per day
(+5.7 breaks/day) in adults of the general population after one week [23]. Similar to the present
study, the stAPP app did not lead to any changes in total daily sitting time. However, neither of these
studies were powered to detect changes in total sitting time. Another smartphone app (B-MOBILE)
that comprised of sedentary behaviour goal-setting, prompting, and feedback significantly reduced
total daily sitting time after one week in overweight/obese adults [24]. This may have been due
to the B-MOBILE app prompting participants to break up their sitting time with 3, 6, or 12 min of
walking every 30, 60, or 120 min, respectively. Furthermore, the app had a greater focus on goals and
self-monitoring of activity breaks than the MyHealthAvatar-Diabetes and stAPP apps, which may
have thus resulted in a greater displacement of sitting time. The MyHealthAvatar-Diabetes app thus
appears to have promise for increasing the number of breaks from sitting, but may need refinement to
encourage reductions in total sitting time in a full trial.
The preliminary effects analysis suggested that the MyHealthAvatar-Diabetes app may increase
the percentage of time spent in light-intensity stepping and total stepping. The B-MOBILE app
significantly increased percentages of time spent in light physical activity, and also increased time
spent in moderate-to-vigorous physical activity [24]. This is in contrast to the stAPP app that did not
cause any changes in physical activity outcomes [23], which may have been because the stAPP app
did not provide any information on steps (monitored in real-time with MyHealthAvatar-Diabetes and
B-MOBILE apps). Functions that enable monitoring of steps thus appear to be important for increasing
light or moderate physical activity in apps designed to reduce sitting time.
To the authors knowledge, this is the first study to evaluate the potential effects of a sitting
reduction smartphone app on health outcomes. Participants that used the MyHealthAvatar-Diabetes
app for 8 weeks had a trend of reduced body fat % and 2-h glucose. This could have been due
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to an increase in the number of breaks from sitting or increases in light stepping achieved by the
intervention group. The capability to set medication reminders and goals in relation to body weight
and glucose within the app may also help with improving these health markers. Further research
is needed to evaluate the effects of the MyHealthAvatar-Diabetes app on sitting behaviour, physical
activity, and health outcomes in a full trial to corroborate the preliminary effects seen in this study.
This study was novel in that it used measurements from the Theory of Planned Behaviour to
investigate the determinants of sitting behaviour. As the data is underpowered, definitive conclusions
cannot be made. However, overall intention increased in favour of the intervention, as did attitude,
suggesting that the intervention may have a positive effect on motivation. Perceived behavioural
control also increased, suggesting that the participants’ belief in their ability to break up their sitting
was improved. However, the subjective norms of others wanting them to break up their sitting was
negatively impacted upon in those who received the intervention, suggesting perceptions of social
influences may need to be targeted in future interventions. All aspects of wellbeing showed a positive
change in favour of the intervention, which shows promise for a fully powered intervention.
Strengths and Limitations
The main strength of this study was the evaluation of an app that was designed using specific
BCTs to encourage reductions in prolonged sitting. This study also established the acceptability
and feasibility of evaluating the MyHealthAvatar-Diabetes app, and the findings can thus be used
to inform a full trial. The limitations of this study include the small sample size, which was based
on pragmatism. This may thus limit the generalisability of the findings. However, the feasibility
of evaluating the MyHealthAvatar-Diabetes app in a full trial can be approached with confidence,
given the high compliance and low dropout rates observed. Although the MyHealthAvatar-Diabetes
app was deemed to be acceptable by the participants, there were a number of issues that could have
limited user engagement. One issue that was often described was the app’s alert to prompt the user to
take a break from sitting being set to automatically occur every 30 min during the day. The participants
indicated that they would have preferred the alerts to be reactive, so that they occurred after the user
had been sitting for 30 min. This modification has since been made to the app for use in a full trial.
Another barrier was the necessity to carry the phone in a trouser pocket for accurate detection of
sitting or standing postures. This was particularly problematic for women who often did not wear
clothing that would allow this. These issues should be considered when developing sitting-based
smartphone apps to maximise user engagement. As discussed previously, it should also be considered
how the MyHealthAvatar-Diabetes app could be adapted in a future trial to encourage reductions in
total daily sitting time. In this study, we did not stipulate that participants should not use other apps
or devices that they already had access to. This was because we wanted to evaluate an intervention
that was in addition to participants’ usual behaviour and healthcare. The current intervention could
have encouraged increased engagement with such apps or devices, which could have affected their
behaviour. Another potential limitation is that the intervention was evaluated only in people with
early-stage T2DM. This limits the generalisability to individuals who have had the disease for a
longer period of time or who are at a more advanced stage. However, our aim was to evaluate if the
intervention could be an effective tool to help manage T2DM at an early stage. It would also be of value
to establish the validity of the MyHealthAvatar-Diabetes app for measuring sitting behaviour to further
support its use as a public health intervention tool and a method for evaluating responses to sedentary
behaviour interventions. Lastly, some of the participants were provided with an Android smartphone
if they did not have access to one already e.g., because they owned an iPhone. This could have affected
their engagement with the MyHealthAvatar-Diabetes app, although this was not mentioned as a
problem during the interviews.
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5. Conclusions
In conclusion, this study suggests that it would be feasible to evaluate the efficacy of the
MyHealthAvatar-Diabetes app for breaking up prolonged sitting in people with T2DM in a fully
powered RCT. The intervention was found to be acceptable, although there are a number of changes
that could be made to the app to increase participant engagement. The MyHealthAvatar-Diabetes app
appeared to have the potential to improve measures of health and wellbeing, further emphasising the
need to evaluate the effects in a full trial.
Supplementary Materials: The following are available online at http://www.mdpi.com/1660-4601/17/12/4414/s1,
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